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3:4:5:6-Dibenzcarbazole has been tested on numerous occasions and has been
shown to be a potent carcinogen in mice.(Boyland and Brues, 1937; Strong,
Smith and Gardner, 1937; Boyland and Mawson, 1938; Andervont, 1939;
Andervont and Edwards, 1941). The results are summarized. in Table I.
Benign and mahgnant cutaneous tumours were observed after skin painting
and subcutaneous sarcomas after injection. In both types ofexperiment distant
tumours were found in the lungs and liver. In the latter organ the changes were
very severe and comprised cirrhosis and bile-duct profiferation, which proceeded
to the formation ofcholangiomas, as weR as hepatomas.
As Boyland and Brues (1937) had suggested that naphthylamine workers
might come in contact with dibenzearbazoles during the c'urse of their work, it
was decided to re-investigate 3:4:5:6-dibenzcarbazole as a potential bladder
carcinogen. For this purpose it seemed proba'ble that much larger doses than
those used hitherto would be required. Mice of,the CBA strain were chosen, as
this strain had previously given a higheryield ofbladder tumours when 2-acetyl-
arninofluorene was fedby stomach tube than four other strains tested (Armstrong
and Bonser, 1947). Later, mice of the Strong A strain were also included, as the
livers of these mice suffered the least damage in the above experiment.
METHOD.
Mice of the two strains CBA and Strong A were used, having been brother-
sister bred in the laboratory. At the age of 12 weeks administration of 3:4:5:6-
dibenzcarbazole, supphed by Professor E. Boyland (Chester Beatty Research
Institute, Royal Cancer Hospital, London), in arachis oil by stomach tube twice
per week was conunenced. The technique of this method of administration is
describedbyArnistrong and Bonser (I944). As themortaHty in CBA niice in the
first few weeks was very high, successive groups were tested at diffe'rent dosage
until a reasonable survival was obtained (Table II). The CBA rnice were treated
until death ; in Strong A n-iice, when it was evident from the swoRen state of the
abdomen that much liver damage had taken place, treatment was continued for
as long as the rnice seemed able to suppo'rt it and was then withheld until death,
the interval in some cases being over 20 weeks (Table III). By this means it was
possible to prolong the hfe ofboth sexes into the period 50 to 60 weeks.
Thebladderwasinspectedwith the naked eye or with thedissecting microscope204 ELIZABETH C. ARMSTRONG AND GEORGIANA M. BONSER
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in all cases, previou-s experience havin shown that it is n-ot difficult to detect
early bladder lesions by these means. A microscopical examination was also
made in approximately one-quaiter ofthe mice.
RESULTS.
Mortality.-In the early weeks the death-rate ofCBA females 'm Experiments
I to III was much greater than that of males (Table 11). Even when, in Experi-
ment III, the dose was reduced to 0-15 mg. per week, a level fairly wefl tolerated
by the males (Experiment Hb), aR the females died before the expiration of 5
weeks. The cause of death was peripheral lobular hver cefl necrosis, upon
which pneumonia supervened. The dose was not found which would permit
the females to live for more than 20 weeks, although 27 out of 60 CBA males
survived from 20 to 49 weeks.
TABLE II.-Five Exper%ment8 in whkh 3:4:5:6-dibenwarbazole Wa8 Admini8tered
to CBA and Strong A Mice in Solution in AracU80il by Stomach Tube Twice
Weekly.
Nuinber of
Expt. mice.
11
F. M.
Deaths.
t A-. Surviva
F. M. (weeks.)
Treatment. Dose
perweek
mg.
Ia . 13 . 15 . 0-2 c.c. of 1 per cent solution re-
duced after one week to 0-1
c.c. of 1 p.r cent solution
Ib . . . 9 . 0-1 c.c. of 1 per cent solution re-
duced after 7 weeks to 0-1 c.c.
of 0-5 per cent solution
lIa . 9 . 11 . 0-1 c.c. of 0-5 per cent solution
4 . 11 . 1 . 1
2 2 14 3-12
2 0 3 - 0-9
1 0 3 - 10-19
0 3 20-39
1 8 4 0-9
0 1 10-19
1 6 20-29
1 0 2 10-19
0 4 20-29
i 0 4 30-49
IIb . .. . 10 . 0-1 ex. of 0-5 per cent solution .
reduced at varying times to
0-1 c.c. of 0-25 per cent solu-
tion
III . 14 . .. . 0-1 c.c. of 0-25 per cent solution .
IV . 13 . 15 . 0-1 c.c. of 0-125 per cent solu- .
tion increased after 6 weeks to
0-1c.c.ofO-25percentsolution
.
I
I
I
14
9
4
0
0
0
0-5
0-9
10-19
20-29
30-39
40-49
0-9
30-39
40-49
50-59
2
3
2
6
2
1
1
6
4
V . 18 . 12 . 0-1 c.c. of 0-125 per cent solu- .
tion increased after 6 weeks
to 0-1 c.c. of 0-25 per cent
solution
I 5 .
1 .
i 1 .
11 .
In experiments I to IV, CBA mice were used. In experiment V, Strong A mice were used.
In Experiment V, Strong A female mice showed only a shght tendency to die
early from the effects ofthe chemical with the dosegiven, 5 out of 18 dying in the
first fewweeks, but when once tolerance had been estabhshed the females survived
rather longer than the males (Table II).
Bladder.-No epithehal changes were observed.
Foredomach-.-Squamous papillomata of the forestomach were observed in a
CBA male mouse after 17 weeks of treatment. In Table III are listed all the0 0 o o o c) o.o c) o o z I
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mice of both stiains which were treated or survived for perio4s of from 17 to 59
weeks. Of 55 mice, 23-6 per cent showed no tumours, 63-6 per cent had papillo-
matosis and 12-7 per cent frank squamous carcinomas. The number ofpapillo-
mata ranged from 1 to 14 or 15 and the size from pinhead to as much as 7 or 8
mm. in diameter. All were fronded, and on microscopical examination were well-
differentiatedkeratinizing squamous papillomas, with a deficate connective-tissue
core (Fig. 1). Several showed such a degree of cellular irregularity in the basal
layers as to be consistent with a diagnosis ofearly mahgnancy, but this diagnosis
was not made unless there was invasion and destruction of the muscular coat of
the stomach of such degree as to leave no doubt as to the invasiveness of the
process. AR the 7 carcinomata were of squamous type (Fig. 2), the largest in
Strong A male 14 attaining a size of 2-0 x 1-4 x 1-4 cm. In CBA Mouse 25
there was extensive spread of cancer via the serosal lymphatics (Fig. 3). These
proliferative changes were entirely confined to the forestomach, the glandular stomach showing on occasion inflanunatory reactions, but no hyperplasia. Nor
was any prohferative lesion of the rest of the intestinal tract observed.
Livem-The livers of all the mice suffered severely. Many of the females
dying during the first few weeks of treatment showed deep yeRow staining of an
tissues and organs and this was attributed to jaundice. Even at 31 weeks early cellular cirrhosis and bile-duct proliferation was observed. By 20 weeks all
the changes were weR established, including nodular regeneration of the paren- chymal cells ; in mice dvine after 40 weeks oftreatmentthey were very advanced
(Fig. 4). The hvers of afl the n-tice of both strains treated for-20 weeks or more
showed bile-duct cystadenomas; in Strong A Mouse 12 and CBA Mouse 28 the
condition had progressed to mahgnancy (Fig. 7). FinaRy hepatomas occurred
(Table'III), somd of which were undoubtedly malignant, metastases to the lungs being observed in Strong A Mouse 22 (Fig. 5, 6). The live'rs were on the whole
larger in Strong A than in CBA mice, but-it was thought that some reduction in
hver size occurred in the mice of the former,strain when the treatment was with-
drawn.
Lung8.-Apart from terminal pneumonia, no hyperplastic nor other changes
were noted in the lungs of CBA rnice. However, in every Strong A mouse fisted
in Table III pulmonary adenomas were observed. No attempt. was made to
count or measure these tumours, but the impression was gained that they were,
on the whole, oflarger size in those mice which were treated until death than in
those in which a long interval elapsed between the cessation of treatment and
death.
Kidnew.-In CBA mice there was evidence of chronic glomerulo-nephritis from 7 weeks onwards. Increasedcellularity ofthe tufts was followedbyhyalini- zation ; metaplasia of Bowman's capsule to a cuboidal type of epithehum also
occurred. There was focal lymphocytic infiltration of the interstitial-tissue,
proceeding to fibrosis, and after 20 weeks of treatment there was usually calcifi-
cation of some of the cortical tubules and of the ad acent glomerular vessels.
The kidneys of 4 Strong A mice were examined microscopically and all were
normal.
Po8terior abdominal wall.-In CBA Mouse 10 a smooth white fleshy tumour
was found at pod-mortem arising from the muscles of the posterior abdominal
waR behijid the rectum. It was invading through the anterior abdominal wan
into the thigh muscles. It was not connected with rectum, testes, bladder,208. ELIZABETH C. ARMSTRONG AND GEORGIANA M. BONSER
ureter norkidneys. On microscopical examination the tumour had the structure
of a spindle-cell sarcoma, in which were very numerous multinucleatedgiant ceRs
of bizarre type.
DISCUSSION.
No changes were observed in the bladders of mice of two strains after pro-
longed andheavydosage with 3:4:5:6-dibenzcarbazole. Itis to benoted, however,
that no CBA mouse survived longer than 49 weeks, while afl but one Strong A
mouse survived into the period 40 to 59 weeks. At 49 weeks only one of 18
CBA mice treated with the potent bladder carcinogen 2-acetylaminofluorene was
known to have developed a tumour (Armstrong and Bonser, 1947), whereas 5
out of 10 S'trong A mice were known to have hyperplasia or a benign papiRoma
when dying between 40 and 59 weeks. Thus, while it cannot be stated with
certainty that 3:4:5:6-dibenzcarbazole administered orany is not a bladder car-
cinogen, no indication has been obtained which would suggest that it has any
action on the bladder epithelium, although from previous experience with these
strains of rnice evidence ofhyperplasia or papiRomatosis might be expected to be
forthcoming within the experimental period available.
An interesting unexpected finding was the high yield of tumours of the fore-
stomach in both strains (Table III). MoreStrong A than CBA mice had tumours
atdeath, but the difference is not statisticaRy significant, and ma' be due to the
greater dose of chernical and the longer survival period in Strong A than in CBA
mice (Table IV). When it is taken into account that the incidence of carcinomas
was identical in the two strains, despite the shorter survival period and smaller
dose in CBA mice, it would appear probable that CBA is the more susceptible
strain. From Table III it is seen that these tumours of the forestomach are not
dependent upon the continued adrninistration of the carcinogen for the main-
tenance of their growth, as the cheniical was discontinued for an average of
10-1 weeks before the death of Strong A m,ice, the range being 0 to 22 weeks.
It is rather surprising that papillomas of the forestomach were so rarely
observed when tar was applied to the skin of ruice, Twort and Twort (1932)
having observed only occasional papifomas in 60,000 mice so treated. Much
EXPLANATION OF PLATES.
FIG. l.-CBA Mouse 8, treated for 23 weeks. Longitudinal section through stomach showing
fore andglandularportions. On the left, threelarge squamouspapillomata and anothertiny
one on thelimitingridge ; on theright, theglandular stomach, free oftumours. One ofthe
papillomata(not shownhere) had invadedthrough the muscular wall ofthe stomach and was
regarded as a squamous cancer. x 3.
FIG. 2.-CRA Mouse 25, treated for 38 weeks. Keratinizing squamous cancer, which has
invaded through the muscular wall of the forestomach (lower margin). x 130.
FiG. 3.-Sairne mouse as in Fig. 2. Invasion of subserosal lymphat-ics of the glandular
stomach by squamoiis cancer of the forestoinach. x 130.
FIG. 4.-CBA Mouse 30, treated for 41 weeks and killed 5 weeks later. Biliary cystadenoma
with cirrhosis. There is a group of hyperplastic bile ducts above, and a regenerative
nodule of liver parenchyma below. X 55.
FIG. 5.-Strong A Mouse 22, treated for 37 weeks and killecl 15 weeks later. Malignant hepa-
tomashowingfinger-like columns oftumour cells, which arehighlyvacuolated, andirregu-
larity of nuclear size. X 130.
FIG. 6.-Same mouse as in Fig. 5. Atrium of bronchus with two deposits of malignant
hepatoma cells in peribronchial lymphatic vessels. x 130.
FIG. 7.-Strong A Mouse 12, treated for 44 weeks and killed 12 weeks later. Acini of
malignant cholangioma with cellular cirrhosis between. x 130.BRITISH JOURNAL OF CANCER. Vol. IV, No. 2.
Armstrong-and Bonser.BRITISH JOURNAL OIF CANCER. Vol. IV, No. 2.
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has been w-ritten about the induction of tumours of the forestomach by means
ofingestion of carcinogenic hydrocarbons, reviews by Klein and Palmer (1941),
Sugiura (1942), Kirby (1943) and Beck (1946) giving a com lete account of the
subject. It seems clear that 20-methyleholanthrene, 3:4-benzpyrene and 1:2:5:6-
dibenzanthracene are carcinogenic in this sense, the latter having produced one
benign tumour (Beck, 1946) and several malignant ones (Lorenz and Ste-wart,
1948). Exhibition in vegetable or mineral oil or in aqueous emulsions or in
aqueous soap solution is effective. The addition of 3:4:5:6-dibenzcarbazole may
now be made to this hst. From the observations so far reported it is necessary
to administer the chemical by the oral route, as no similar tumours were found
after skin painting or subcutaneous injection. Itis concluded that the chemical
acts locaRy on the epitheHum of the forestomach.
TABLEIV.-Incidence ofForedomach Tumour8, "th Average Survival andD08age
of the Mice.
Strong A. CBA.
No tumour 16-7 29-0
Tumour incidence Papilloma 70-8 58-0
Carcinoma 12-5 13-0
Weeks. Weeks.
No tumour 50.0 25-2
Average survival Papilloma 50-6 31-2
Carcinoma 47
- 7 33-6
mg. mg
No tumour 17-3 11-1
Average dose per mouse Papiuom'a 18-9 14-2
Careinoirna 17-7 14-6
Miniinum dose per mouse Papinoms 14-5 7-0
Carcinoma 16-0 10.0
Maxiinum dose per mouse No tumour 21-0 17-5
No tumours of the glandular stomach were observed. The reasons given by
Beck (I946) may account for this: the presence ofthe mucus barrier, the mucus
flow tending to remove the carcinogen from contact with the cefls, the possibifity
that contact between a carcinogen and a resting cell may not be sufficient to
induce neoplasia, and finaRy the possibifity that glandular epithehum is essen-
tiaRy less susceptible than squamous epithelium to the type ofcarcinogen under
discussion. There seems to be httle support for ihe latter suggestion when the
recentwork (Iforning, 1946 ; Pan andGardner, 1948) on the induction oftumours
by carcinogens in glandular epitheha in implants is considered. Carcinomas of
the intestine were notobserved, in contrast with the results ofLorenz and Stewart
(1946), who noted such tumours in Strain A and other mice wbich received
aqueous emulsions of 20-methylcholanthrene and 1:2:5:6-dibenzanthracene.
Amines are not without a similar action on theepithehum ofthe forestomach,
papillomas having been observed in one RIII, one CBA and 2 Strong A mice at
771 74) 69 and 65 weeks respectively of treatment with 2-acetylaml'n'ofluorene
(Armstrong and Bonser, 1947). In addition, Otsuka (1935) described papiRoma-
tosis of the forestomach in rnice foRowing oral administration of diaminoazo-
benzene.
One spindle-ceR sarcoma of the posterior abdominal wafl was observed. It210 ELIZABETH' C. ARMSTRONG AND GEORGIANA M. BONSER
seems possible that perforation of the stomach might have occurred during intu-
bation, resulting in a false passage of the tube into the muscles of the posterior
abdominal waR and consequent injection of-the chemical at this site. In the
course of observation of the CBA strain for 17 years (unpubfished observation),
one spontaneous spindle-cefl sarcoma has been found and, therefore, the possi-
bility of a spontaneous origin of the tumour in Mouse 10 cannot be completely
excluded.
The pulmonary tumours observed in strain A rnice were similar to those
described by Andervont (1939).
Thus neoplasia may be expected whenever 3:4:5:6-dibenzcarbazole comes in
contact with the tissues in sufficient concentration. Its general use as a
carcinogen has no doubt beenprevented by its severe toxic action on the hver,
especially in females. Contrary to theexperience of Andervont and Edwards
(1941), this sex difference was observed only in the early weeks of the present
experiment in strain A mice (Table III).
In comparing the degree of fiver damage in the two strains, it is evident that
both suffered severely, but that the incidence ofhepatomas was greater in strain
A naice than in CBA, the proportion of histologically malignant tumours being
also greater. It is probable that this was due to the longer survival and greater
dosage of the chernical in the former strain (Table IV). The contrast between
the liver lesions induced by 2-acetylarninofluorene and 3:4:5:6-dibenzc,arbazole is
very striking. Not only were hepatomas more abundant and more mahgnant in
Strong A mice than in CBA with the latter cheniical, but cirrhosis and bile-duct
proliferation were a marked feature in both strains. Although a high incideDce
ofhepatomas was obseirved in CBA niice (but not in Strong A mice) when treated
with 2-acetylaminofluorene (Arms'trong and Bonser, 1947), cirrhosis was absent
and bile duct changes were
i 'mal. It would appear possible that the chief
action of 2-acetylaminofluorene is to enhance the tendency to hepatoma already
hereditarily present in CBA raice, whereas 3:4:5:6-dibenzcarbazole damages the
liver parenchyma in such a way that changes are set in train which eventually
lead to tumour formation (Orr 1940).
SUMMARY.
An experiment is described in which m,ice of the Strong A and CBA strains
received by stomach tube, twice weekly, an oily solution of 3:4:5:6-dibenzcar-
bazole, with a view to testing this substance as a bladder carcinogen. The
mortality was veryhigh until the dose was reduced to 0-5 mg. per mouse perweek,
the cause of death being necrosis of the hver parenchyma. Females were more
susceptible than males, CBA females being more susceptible than Strong A.
No bladder epithehal changes were observed during an experimental period which would have sufficed to show, in these strains, hyperplasia andearly tumour
formation had 2-acetylaminofluorene been the carcinogen. Papifomatosis and carcinomas of the forestomach were observed in both
sexes of both strains. The extreme liver changes observed by previous authors
were also seen.
We wish to thank Professor E. Boyland for his generousgift of 3:4:5:6-dibenz-
carbazole.CARCINOMA OF FORESTOMACH IN MICE 211.
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